Inhaled Beclomethasone to Prevent Chronic Lung Disease
NCT00000576 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2016-02-18
Summary
To test if inhaled glucocorticoids, early in the course of respiratory failure in premature infants, permit normal lung growth and differentiation, thus preventing development of bronchopulmonary dysplasia.
Conditions
- Bronchopulmonary Dysplasia
- Hyaline Membrane Disease
- Lung Diseases
Interventions
- DRUG
-
beclomethasone
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
lead NIH
Study Design
- Allocation
- RANDOMIZED
Eligibility
- Max Age
- 1 Year
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1993-06-30
- Completion
- 1999-04-30
More Related Trials
-
Intra-tracheal Instillation of Budesonide to Prevent Chronic Lung Disease
NCT05364385 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy of Adding Budesonide to Poractant Alfa to Prevent Bronchopulmonary Dysplasia.
NCT03521063 ·Status: UNKNOWN ·Phase: PHASE4
-
PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary Dysplasia
NCT07101640 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Prevention of Chronic Lung Disease (CLD) in Preterm Infants
NCT00883532 ·Status: UNKNOWN ·Phase: PHASE4
-
Inhaled NO in Prevention of Chronic Lung Disease
NCT00000548 ·Status: COMPLETED ·Phase: PHASE3
-
Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants
NCT00006401 ·Status: COMPLETED ·Phase: PHASE3
-
Glucocorticoids and Pulmonary Hypertension
NCT04499196 ·Status: UNKNOWN
-
Inhaled Extra-fine Hydrofluoalkane-beclomethasone (QVAR) in Premature Infants With Bronchopulmonary Dysplasia (BPD)
NCT01373008 ·Status: UNKNOWN ·Phase: PHASE2
-
Inhaled Budesonide for Non-ventilated Infants at High Risk of Bronchopulmonary Dysplasia: the i-BUD Pilot Study
NCT01895075 ·Status: WITHDRAWN ·Phase: PHASE2
-
Lung Function and Structure in Healthy Infants and Infants With Recurrent Wheezing
NCT00507676 ·Status: COMPLETED
-
Intratracheal Budesonide With Surfactant to Prevent Bronchopulmmonary Dysplasia.
NCT04862377 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Dexamethasone Therapy in VLBW Infants at Risk of CLD
NCT00011362 ·Status: COMPLETED ·Phase: PHASE3
-
The Bronchiolitis in Hospitalized Infants Study
NCT05994183 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Pilot Study of Topical Steroid for Prevention of Chronic Lung Disease in Extremely Premature Infants.
NCT01268215 ·Status: UNKNOWN ·Phase: PHASE2
-
The Efficacy and Safety of Montelukast Sodium in the Prevention of Bronchopulmonary Dysplasia
NCT01717625 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Bethanechol on Tracheobronchomalacia
NCT05299008 ·Status: RECRUITING
-
Bronchiolitis in Infants Placebo Versus Epinephrine and Dexamethasone Study
NCT03567473 ·Status: COMPLETED ·Phase: PHASE3
-
Steroids Helping Albuterol Responders Exclusively
NCT00798616 ·Status: WITHDRAWN ·Phase: NA
-
Effectiveness of Inhaled Corticosteroids in Preschool Children With Acute Dyspnea and Wheeze
NCT00962299 ·Status: TERMINATED ·Phase: PHASE4
-
Steroids and Surfactant in Extremely Low Gestation Age Infants Dose Escalation Trial
NCT02907593 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Budesonia + Intratracheal Surfactant in Incidence of Bronchopulmonary Dysplasia
NCT05534685 ·Status: UNKNOWN ·Phase: NA
-
Inhaled Budesonide in Transient Tachypnea of the Newborn
NCT04758078 ·Status: UNKNOWN ·Phase: NA
-
Budesonide With Intratracheal Surfactants in Extremely Preterm Infants
NCT04019106 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Study to Justify Steroid Use in Preterm Neonates to Prevent Bronchopulmonary Dysplasia
NCT03035214 ·Status: UNKNOWN ·Phase: PHASE2
-
Recurrent Wheezing in Infants: Risk Factors and Prevention With Probiotics.
NCT02113072 ·Status: COMPLETED ·Phase: PHASE3